• Nanosonics posts FY26 revenue growth and prepares to launch CORIS

    Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital

    The Nanosonics Ltd (ASX: NAN) share price is in focus today after the company posted FY26 revenue of $203.9 million, up 3% on the prior year, and reported strong growth in trophon unit placements and successful launches of next-generation devices.

    What did Nanosonics report?

    • Revenue increased 3% on prior corresponding period (pcp) to $203.9 million, or 6% on a constant currency basis to $211.5 million
    • EBIT came in at $16.0 million, down 10% on pcp, but up 21% to $21.6 million at constant currency
    • trophon-only EBIT was $50.6 million, a 5% increase on pcp (16% at constant currency)
    • Total trophon unit placements rose 9% to 4,230 units, with global installed base up 6% to 39,230 devices
    • Cash and cash equivalents stood at $155.2 million as at 30 June 2026, and the company remains debt free
    • $20 million share buyback completed, with a new buyback of up to $40 million announced for FY27

    What else do investors need to know?

    Nanosonics launched its next generation trophon3 and trophon2 Plus systems during FY26, seeing accelerating adoption in the second half of the year. North America was a key driver, with record device upgrades up 32% on last year.

    The company continued making headway with the CORIS System, progressing through a Controlled Market Release and receiving favourable customer feedback. Regulatory milestones were achieved, including approvals in major markets and FDA clearances.

    What did Nanosonics management say?

    CEO and President said Michael Kavanagh said:

    Nanosonics is entering a defining period of growth. FY26 demonstrated the strength of the business we have built: a proven trophon franchise, disciplined financial execution and in FY27 we will progress the CORIS System from CMR to commercialisation.

    What’s next for Nanosonics?

    Looking ahead, Nanosonics expects continued revenue growth driven by its expanding trophon installed base, upgrades, and consumables and services. The commercial launch of CORIS is planned across the UK, Ireland and Australia in the first half of FY27, with the US to follow.

    The company has flagged a deliberate increase in operational expenses to support the CORIS commercialisation, but remains well-funded to pursue long-term opportunities. FY27 revenue guidance is between $220 million and $228 million (constant currency) with gross margin expected to moderate as new investments ramp up.

    Nanosonics share price snapshot

    Over the past 12 months, Nanosonics shares have declined 10%, trailing the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.

    View Original Announcement

    The post Nanosonics posts FY26 revenue growth and prepares to launch CORIS appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Nanosonics right now?

    Before you buy Nanosonics shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Nanosonics wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Nanosonics. The Motley Fool Australia has recommended Nanosonics. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Electro Optic Systems half-year earnings surge on booming defence demand

    Two work colleagues looking at a laptop and discussing something.

    The Electro Optic Systems Holdings Ltd (ASX: EOS) share price is on watch today after the company unveiled surging half-year revenue, which jumped 283% to $168.8 million, though its net loss after tax narrowed to $32.9 million.

    What did Electro Optic Systems report?

    • Revenue from continuing operations up 283% to $168.8 million (1H FY25: $44.1 million)
    • Net loss after tax attributable to members reduced to $32.9 million (1H FY25: loss of $44.8 million)
    • Underlying EBITDA from continuing operations swung to a profit of $21.6 million (1H FY25: $14.9 million loss)
    • No interim dividend declared
    • Contracted order book grew to approximately $846 million (1H FY25: $170 million)
    • Net assets stood at $391.6 million at 30 June 2026, with cash and equivalents at $256 million

    What else do investors need to know?

    Electro Optic Systems completed its acquisition of the MARSS Group in May, boosting its offering in the fast-growing counter-drone and advanced defence tech sector. The MARSS business is now integrated with EOS’s Defence Systems division, strengthening the group’s position in Europe and the Middle East.

    The half also saw EOS undertake a major $190 million capital raise and secure a new $100 million loan facility, of which $70 million has been drawn. The company continues to invest heavily in research and development, with a particular focus on high-energy laser weapons and fully integrated counter-drone solutions.

    What’s next for Electro Optic Systems?

    EOS expects continued strong demand driven by defence spending and escalating interest in counter-drone technologies globally. The company’s contracted order book now stands at $846 million, underpinning future revenue.

    Management forecasts full-year 2026 revenue (including MARSS) of $360 million to $400 million—potentially a record result—assuming global supply chains remain steady. The company says it will keep the market updated as major deals progress, especially in key regions like Europe, the Middle East, and North America.

    Electro Optic Systems share price snapshot

    The EOS share price has been among the best performers on the S&P/ASX 200 index (ASX: XJO) over the past 12 months with a gain of 70%.

    View Original Announcement

    The post Electro Optic Systems half-year earnings surge on booming defence demand appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Electro Optic Systems right now?

    Before you buy Electro Optic Systems shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Electro Optic Systems wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Why every Aussie investor should own one of these ASX ETFs

    ETF on wooden blocks, with finance images on top.

    Australian investors have plenty of opportunities for capital growth with domestic stocks.

    However, some investors might not be aware the Aussie market is heavily weighted towards big banks and mining companies.

    In reality, the S&P/ASX 200 Index (ASX: XJO) is one of the most concentrated developed-market indices on the planet.

    According to VanEck, the top 5 securities account for roughly 32% of the ASX 200 Index. 

    This means that many investors might be overexposed to the performance of these blue-chip stocks without realising. 

    Why international ETFs make sense

    A key point to remember is that diversifying internationally doesn’t necessarily mean abandoning the ASX. 

    An Australian investor can retain domestic exposure while using ASX-listed international ETFs to broaden their portfolio.

    This can transform a portfolio that is heavily dependent on Australian banks and miners into one with much broader exposure to the global economy.

    Sectors like technology and healthcare are underrepresented here in Australia. 

    By targeting international ASX ETFs, Aussie investors can gain exposure to these underrepresented markets. 

    In short, the more concentrated the home market, the greater the potential benefit from looking beyond it. 

    For Australian investors, international ASX ETFs can complement domestic holdings by diversifying sectors, companies, economies, and sources of growth.

    With that in mind, here are three international funds that can provide instant geographic diversification. 

    Vanguard MSCI Index International Shares ETF (ASX: VGS)

    This is one of the most popular internationally focused ASX ETFs. 

    It complements an Australian-dominated portfolio as it includes 1,300 companies from 23 developed countries, excluding Australia. 

    The fund offers greater access to sectors such as technology and health care that aren’t as well represented in the Australian share market.

    In the last 5 years, it has risen more than 54%, vastly outpacing the ASX 200. 

    iShares S&P 500 ETF (ASX: IVV)

    Another popular fund focused on overseas equities is this ASX ETF from iShares. 

    The fund aims to provide investors with the performance of the S&P 500 Index (SP: .INX), before fees and expenses. 

    The index is designed to measure the performance of large capitalisation US equities.

    Its high growth profile is heavily weighted towards technology companies, including Nvidia and Apple. 

    In the last 5 years, it has increased by an impressive 70%. 

    BetaShares Nasdaq 100 ETF (ASX: NDQ)

    For investors looking for a more highly concentrated US exposure, this fund is an ideal candidate. 

    It aims to track the performance of the NASDAQ-100 Index (NASDAQ: NDX) (before fees and expenses). 

    The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the Nasdaq market, and includes many companies that are at the forefront of the new economy.

    In the last 5 years, it’s enjoyed a rise of roughly 75%. 

    The post Why every Aussie investor should own one of these ASX ETFs appeared first on The Motley Fool Australia.

    Should you invest $1,000 in BetaShares Nasdaq 100 ETF right now?

    Before you buy BetaShares Nasdaq 100 ETF shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and BetaShares Nasdaq 100 ETF wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Bell has positions in BetaShares Nasdaq 100 ETF and Vanguard Msci Index International Shares ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended BetaShares Nasdaq 100 ETF and iShares S&P 500 ETF. The Motley Fool Australia has positions in and has recommended BetaShares Nasdaq 100 ETF. The Motley Fool Australia has recommended Vanguard Msci Index International Shares ETF and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Sorry, but nothing was found. Please try a search with different keywords.